Buy Cipla, target price Rs 685: Elara Capital

Cipla’s recent inhaler approval of generic of Proventil from the USFDA would aid in strong earnings visibility in the near term.

from Stocks-Markets-Economic Times https://ift.tt/2xaxGWg

Comments

Popular posts from this blog

SBI to meet RBI brass on Aircel insolvency